Improved survival rates demonstrated in mouse models of aggressive human leukemia using leukemia cells taken directly from patients, according to new EBioMedicine study A team of researchers led by Fatih M. Uckun, MD, PhD, of The Saban Research Institute of Children's Hospital Los Angeles and Professor at the University of Southern California Keck School of Medicine has determined that radiation resistance in leukemia can be overcome by using an engineered protein they recently designed and developed as a new precision medicine against leukemia. This study has been published in open access journal EBioMedicine .
http://ift.tt/19nExd0
http://ift.tt/19nExd0
No comments:
Post a Comment